Total Payments
$17,332
2024 Payments
$1,689
Companies
64
Transactions
803
Medicare Patients
10,382
Medicare Billing
$1.5M
Payment Breakdown by Category
Food & Beverage$17,103 (98.7%)
Travel$143.78 (0.8%)
Consulting$64.00 (0.4%)
Education$21.29 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $17,103 | 799 | 98.7% |
| Travel and Lodging | $143.78 | 1 | 0.8% |
| Consulting Fee | $64.00 | 1 | 0.4% |
| Education | $21.29 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $2,711 | 87 | $0 (2024) |
| Boston Scientific Corporation | $1,085 | 36 | $0 (2024) |
| Collegium Pharmaceutical, Inc. | $1,015 | 58 | $0 (2024) |
| SI-BONE, INC. | $980.88 | 14 | $0 (2024) |
| ABBVIE INC. | $859.23 | 42 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $823.65 | 55 | $0 (2024) |
| Daiichi Sankyo Inc. | $722.17 | 80 | $0 (2019) |
| Vertos Medical, Inc. | $653.55 | 10 | $0 (2024) |
| IBSA Pharma Inc. | $535.18 | 36 | $0 (2024) |
| Scilex Pharmaceuticals Inc. | $523.78 | 31 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,689 | 80 | Vertos Medical, Inc. ($315.31) |
| 2023 | $1,883 | 74 | AbbVie Inc. ($277.87) |
| 2022 | $2,001 | 70 | Abbott Laboratories ($372.31) |
| 2021 | $1,831 | 94 | AbbVie Inc. ($256.89) |
| 2020 | $1,578 | 72 | Abbott Laboratories ($319.75) |
| 2019 | $1,613 | 87 | Scilex Pharmaceuticals Inc. ($216.86) |
| 2018 | $3,352 | 169 | Abbott Laboratories ($1,104) |
| 2017 | $3,385 | 157 | BOSTON SCIENTIFIC CORPORATION ($484.53) |
All Payment Transactions
803 individual payment records from CMS Open Payments — Page 1 of 33
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $12.75 | General |
| Category: NEUROLOGY | ||||||
| 12/11/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $22.74 | General |
| Category: Opioid Analgesic | ||||||
| 12/11/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: Neuromodulation | ||||||
| 11/27/2024 | Stryker Corporation | MILD DEVICE KIT (Device) | Food and Beverage | In-kind items and services | $26.02 | General |
| Category: INSTRUMENTS | ||||||
| 11/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug), RELISTOR | Food and Beverage | In-kind items and services | $21.22 | General |
| Category: Gastroenterology | ||||||
| 11/26/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart | Food and Beverage | Cash or cash equivalent | $19.10 | General |
| Category: Endocrinology | ||||||
| 11/18/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $9.28 | General |
| Category: PAIN | ||||||
| 11/13/2024 | Fidia Pharma USA Inc. | HYMOVIS (Device) | Food and Beverage | In-kind items and services | $29.73 | General |
| Category: OSTEOARTHRITIS | ||||||
| 11/12/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $21.82 | General |
| Category: Opioid Analgesic | ||||||
| 11/06/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug), RELISTOR | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: Gastroenterology | ||||||
| 11/06/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug), RELISTOR | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: Gastroenterology | ||||||
| 11/05/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $27.93 | General |
| Category: NEUROLOGY | ||||||
| 11/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug), RELISTOR | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: Gastroenterology | ||||||
| 10/22/2024 | Stryker Corporation | MILD DEVICE KIT (Device) | Food and Beverage | In-kind items and services | $27.83 | General |
| Category: INSTRUMENTS | ||||||
| 10/17/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $23.62 | General |
| Category: NEUROLOGY | ||||||
| 10/16/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $28.33 | General |
| 10/08/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart | Food and Beverage | Cash or cash equivalent | $23.21 | General |
| Category: Endocrinology | ||||||
| 10/08/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $20.40 | General |
| Category: Opioid Analgesic | ||||||
| 10/03/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart | Food and Beverage | Cash or cash equivalent | $17.42 | General |
| Category: Endocrinology | ||||||
| 09/30/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: PAIN | ||||||
| 09/24/2024 | Stryker Corporation | MILD DEVICE KIT (Device) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: INSTRUMENTS | ||||||
| 09/23/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $22.42 | General |
| Category: PAIN | ||||||
| 09/20/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $22.05 | General |
| Category: Opioid Analgesic | ||||||
| 09/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug), RELISTOR | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: Gastroenterology | ||||||
| 09/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug), RELISTOR | Food and Beverage | In-kind items and services | $22.64 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 33 | 2,317 | 8,955 | $1.9M | $354,736 |
| 2022 | 35 | 2,668 | 12,027 | $2.2M | $414,489 |
| 2021 | 37 | 2,740 | 5,745 | $2.1M | $375,598 |
| 2020 | 33 | 2,657 | 5,856 | $1.8M | $323,997 |
Total Patients
10,382
Total Services
32,583
Medicare Billing
$1.5M
Procedure Codes
138
All Medicare Procedures & Services
138 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2023 | 194 | 291 | $344,890 | $62,419 | 18.1% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 70 | 85 | $180,180 | $34,608 | 19.2% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2023 | 117 | 168 | $187,200 | $29,636 | 15.8% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Office | 2023 | 128 | 151 | $147,980 | $29,352 | 19.8% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Office | 2023 | 120 | 146 | $136,800 | $22,767 | 16.6% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2023 | 67 | 81 | $72,150 | $18,349 | 25.4% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2023 | 113 | 158 | $90,090 | $15,251 | 16.9% |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | Office | 2023 | 58 | 76 | $75,240 | $14,687 | 19.5% |
| 64490 | Injection of upper or middle spine facet joint using imaging guidance, single level | Office | 2023 | 61 | 90 | $78,810 | $14,576 | 18.5% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Office | 2023 | 116 | 164 | $67,240 | $13,995 | 20.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 120 | 155 | $69,750 | $13,352 | 19.1% |
| 0275T | Removal of bone from lower spine for decompression of nerve tissue using imaging guidance, accessed through the skin | Facility | 2023 | 15 | 15 | $52,500 | $12,763 | 24.3% |
| J7324 | Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | Office | 2023 | 21 | 95 | $42,750 | $9,590 | 22.4% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 105 | 160 | $46,920 | $8,888 | 18.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 101 | 132 | $42,240 | $8,627 | 20.4% |
| 64633 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 19 | 23 | $38,750 | $7,923 | 20.4% |
| 64491 | Injection of upper or middle spine facet joint using imaging guidance, second level | Office | 2023 | 57 | 85 | $35,700 | $6,986 | 19.6% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2023 | 44 | 67 | $37,800 | $6,131 | 16.2% |
| 77002 | Fluoroscopic guidance for needle placement | Office | 2023 | 54 | 66 | $28,380 | $5,871 | 20.7% |
| 64634 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2023 | 19 | 25 | $19,170 | $4,982 | 26.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 36 | 36 | $20,880 | $4,250 | 20.4% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 207 | 341 | $6,820 | $1,960 | 28.7% |
| 20552 | Injection of trigger points, 1-2 muscles | Office | 2023 | 35 | 42 | $7,980 | $1,629 | 20.4% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2023 | 25 | 30 | $6,600 | $1,346 | 20.4% |
| 64405 | Injection of anesthetic agent and/or steroid into upper neck and back of head nerve | Office | 2023 | 15 | 16 | $5,400 | $1,062 | 19.7% |
About Dr. Rae Davis, M.D
Dr. Rae Davis, M.D is a Physical Medicine & Rehabilitation healthcare provider based in Lansdowne, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1801822630.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rae Davis, M.D has received a total of $17,332 in payments from pharmaceutical and medical device companies, with $1,689 received in 2024. These payments were reported across 803 transactions from 64 companies. The most common payment nature is "Food and Beverage" ($17,103).
As a Medicare-enrolled provider, Davis has provided services to 10,382 Medicare beneficiaries, totaling 32,583 services with total Medicare billing of $1.5M. Data is available for 4 years (2020–2023), covering 138 distinct procedure/service records.
Ad
Practice Information
- Specialty Physical Medicine & Rehabilitation
- Other Specialties Interventional Pain Medicine
- Location Lansdowne, VA
- Active Since 06/23/2006
- Last Updated 07/24/2019
- Taxonomy Code 208100000X
- Entity Type Individual
- NPI Number 1801822630
Products in Payments
- XTAMPZA (Drug) $836.40
- RELISTOR (Drug) $726.99
- UBRELVY (Drug) $683.61
- mild Device Kit (Device) $653.55
- Proclaim Family of SCS IPGs (Device) $581.34
- SCS IPGs (Device) $564.31
- iFuse Implant (Device) $553.12
- Horizant (Drug) $523.08
- Morphabond ER (Drug) $461.90
- QULIPTA (Drug) $454.42
- NURTEC ODT (Drug) $445.95
- PROCLAIM (Device) $394.64
- EUFLEXXA (Device) $386.16
- ARTISAN (Device) $368.46
- VYEPTI (Biological) $310.56
- Tirosint (Drug) $307.54
- Movantik (Drug) $290.23
- ZOHYDRO ER (Drug) $273.76
- Neuromodulation Dspsbls and Accs (Device) $254.11
- ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH (Drug) $251.93
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.